Induction immunosuppression with interleukin-2 receptor antibodies (basiliximab and daclizurnab) in renal transplant recipients Article

Nair, MP, Nampoory, MRN, Johny, KV et al. (2001). Induction immunosuppression with interleukin-2 receptor antibodies (basiliximab and daclizurnab) in renal transplant recipients . Transplantation Proceedings, 33(5), 2767-2769. 10.1016/S0041-1345(01)02184-4

cited authors

  • Nair, MP; Nampoory, MRN; Johny, KV; Costandi, JN; Abdulhalim, M; El-Reshaid, W; Al-Muzairai, I; Ninan, VT; Samhan, M; Al-Mousawi, M

sustainable development goals

authors

publication date

  • August 1, 2001

published in

keywords

  • ACUTE REJECTION
  • Immunology
  • Life Sciences & Biomedicine
  • MONOCLONAL-ANTIBODY
  • PLACEBO
  • PREVENTION
  • RANDOMIZED-TRIAL
  • Science & Technology
  • Surgery
  • THERAPY
  • Transplantation

Digital Object Identifier (DOI)

start page

  • 2767

end page

  • 2769

volume

  • 33

issue

  • 5